Method for increasing the content of polyunsaturated long-chained fatty acids in transgenic organisms

• US 7,842,852 B2
• Filed: 07/15/2005
• Issued: 11/30/2010
• Est. Priority Date: 07/16/2004
• Status: Expired due to Fees

• Current Assignee: BASF Plant Science GmbH (BASF SE)
• Original Assignee: BASF Plant Science GmbH (BASF SE)
• Inventors: Cirpus, Petra, Qiu, Xiao, Vrinten, Patricia, Bauer, Jorg
• Primary Examiner(s): O Hara; Eileen B
• Application Number:
  US11/632,555
• Publication Number:
  US 20080076164A1
• Time in Patent Office: 1,964 Days
• Field of Search: None
• US Class Current: 800/278
• CPC Class Codes: C12N 15/8247 involving modified lipid metabolism, e.g. seed oil composition
• CPC Class Codes: C12N 9/0006 acting on CH-OH groups as donors (1.1)
• CPC Class Codes: C12N 9/20 Triglyceride splitting, e.g. by means of lipase
• CPC Class Codes: C12N 9/88 Lyases (4.)

Abstract

The present invention relates to a method for increasing the content of polyunsaturated long-chain fatty acids in an organism by introducing nucleic acids coding for polypeptides or proteins exhibiting a phospholipase, ketoacyl-CoA reductase and/or dehydratase activity. The present invention also provides nucleic acid sequences coding for polypeptides with enzyme activities of a phospholipase, ketoacyl-CoA reductase and/or dehydratase, and nucleic acid constructs, vectors and organisms containing the nucleic acid sequences according to the present invention. A further part of the present invention relates to oils, lipids and/or fatty acids produced according to the method of the present invention and the use thereof. Furthermore, the present invention relates to unsaturated fatty acids and triglycerides having an increased content of unsaturated fatty acids and the use thereof.

Claims

1. A method for producing oils and/or lipids having a high content of polyunsaturated fatty acids containing at least two double bonds in a transgenic organism comprising:

a) introducing at least one nucleic acid sequence coding for a polypeptide exhibiting a phospholipase A2 activity into an organism,

b) cultivating the organism.

2. The method according to claim 1, characterized in that the oil and/or lipid is isolated from the transgenic organism.

3. The method according to claim 1, characterized in that the nucleic acid sequence coding for a polypeptide or a protein exhibiting phospholipase A2 activity is selected from the group consisting of:

a) a nucleic acid sequence having the sequence depicted in SEQ ID NO;

1,

b) a nucleic acid sequence which encodes the amino acid sequence depicted in SEQ ID NO;

2, and

c) a derivative of the nucleic acid sequence depicted in SEQ ID NO;

1 coding for a polypeptide or a protein having at least 70% identity at the amino acid level to SEQ ID NO;

2 and exhibiting phospholipase A2 activity.

4. The method according to claim 1, characterized in that at least one nucleic acid sequence coding for a polypeptide or a protein exhibiting Δ

-12 desaturase, Δ

-9 elongase, Δ

-8 desaturase, Δ

-6 desaturase, Δ

-6 elongase, Δ

-5 desaturase, Δ

-5 elongase, ω

-3 desaturase, Δ

-4 desaturase activity is additionally introduced into the organism.

5. The method according to claim 1, characterized in that the oil and/or lipid is selected from the group consisting of linoleic acid, γ

-linolenic acid, stearidonic acid, dihomo-γ

-linolenic acid, ω

-3-eicosatetraenoic acid, arachidonic acid, eicosapentaenoic acid, ω

-6-docosapentaenoic acid, ω

-6-docosatetraenoic acid, ω

-3-docosapentaenoic acid and docosahexaenoic acid.

6. The method according to claim 1, characterized in that the polyunsaturated fatty acids are isolated from the oil and/or lipid in the form of free fatty acids.

7. The method according to claim 6, characterized in that the free fatty acids are isolated at a concentration of at least 5% by weight, based on the total lipid content of the transgenic organism.

8. The method according to claim 1, characterized in that the transgenic organism is a transgenic microorganism or a transgenic plant.

9. The method according to claim 1, characterized in that the transgenic organism is an oil-producing plant, a vegetable plant, or an ornamental plant.

10. The method according to claim 1, characterized in that the transgenic organism is a transgenic plant selected from the group consisting of plant classes or families:

Adelotheciaceae, Anacardiaceae, Asteraceae, Apiaceae, Betulaceae, Boraginaceae, Brassicaceae, Bromeliaceae, Caricaceae, Cannabaceae, Convolvulaceae, Chenopodiaceae, Crypthecodiniaceae, Cucurbitaceae, Ditrichaceae, Elaeagnaceae, Ericaceae, Euphorbiaceae, Fabaceae, Geraniaceae, Gramineae, Juglandaceae, Lauraceae, Leguminosae, Linaceae and Prasinophyceae.

11. A method for producing an oil, lipid or fatty acid composition by mixing oil, lipids or fatty acids according to claim 1 with animal oil, lipids or fatty acids.

12. The method according to claim 1, wherein the at least one nucleic acid sequence coding for a polypeptide exhibiting a phospholipase A2 activity codes for a protein having at least 95% identity at the amino acid level to SEQ ID NO:

2 and exhibiting phospholipase A2 activity.

13. An isolated nucleic acid molecule comprising a nucleic acid sequence coding for a polypeptide or a protein exhibiting phospholipase A2 activity, characterized in that the nucleic acid sequence is selected from the group consisting of:

a) a nucleic acid sequence having the sequence depicted in SEQ ID NO;

1,

b) a nucleic acid sequence which encodes the amino acid sequence depicted in SEQ ID NO;

2, and

c) a derivative of the nucleic acid sequence depicted in SEQ ID NO;

1, which codes for a polypeptide or a protein having at least 70% homology at the amino acid level to SEQ ID NO;

2 and exhibiting a phospholipase A2 activity.

14. The isolated nucleic acid molecule according to claim 13, wherein the nucleic acid sequence is originated from an alga, a fungus, a microorganism, a plant, or a non-human animal.

15. The isolated nucleic acid molecule according to claim 13, wherein the nucleic acid sequence is originated from the order Salmoniformes, the diatoms genera Thalassiosira or Crypthecodinium, the classes Prasinophyceae or Phycomycota, or the families Euglenaceae or Pythiaceae.

16. A polypeptide comprising an amino acid sequence encoded by the isolated nucleic acid molecule according to claim 13.

17. A gene construct containing the isolated nucleic acid molecule according to claim 13, wherein the nucleic acid molecule is functionally linked to one or more regulatory signals.

18. The Gene construct according to claim 17, characterized in that the gene construct contains at least one additional biosynthesis gene of the fatty acid or lipid metabolism selected from the group consisting of:

acyl-CoA dehydrogenase(s), acyl-ACP [=acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s), fatty acid acyltransferase(s), acyl-CoA;

lysophospholipid acyltransferase(s), fatty acid synthase(s), fatty acid hydroxylase(s), acetyl-Coenzyme A carboxylase(s), acyl-Coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acetylenase(s), lipoxygenase(s), triacylglycerol lipase(s), allene oxide synthase(s), hydroperoxide lyases and fatty acid elongase(s).

19. The gene construct according to claim 17, characterized in that the gene construct contains at least one additional biosynthesis gene of the fatty acid or lipid metabolism selected from the group consisting of Δ

-4 desaturase, Δ

-5 desaturase, Δ

-6 desaturase, Δ

-8 desaturase, Δ

-9 desaturase, Δ

-12 desaturase, Δ

-6 elongase, Δ

-5 elongase and Δ

-9 elongase.

20. A vector containing the nucleic acid molecule according to claim 13.

21. A transgenic non-human organism containing at least one nucleic acid molecule according to claim 13.

22. The transgenic non-human organism according to claim 21, wherein the organism is a plant.

23. The isolated nucleic acid molecule according to claim 13, wherein the nucleic acid sequence codes for a protein having at least 95% identity at the amino acid level to SEQ ID NO:

2 and exhibiting phospholipase A2 activity.